137 related articles for article (PubMed ID: 33665869)
21. Extracorporeal photopheresis reduces the number of mononuclear cells that produce pro-inflammatory cytokines, when tested ex-vivo.
Bladon J; Taylor P
J Clin Apher; 2002; 17(4):177-82. PubMed ID: 12494410
[TBL] [Abstract][Full Text] [Related]
22. Apoptosis induction of ultraviolet light A and photochemotherapy in cutaneous T-cell Lymphoma: relevance to mechanism of therapeutic action.
Yoo EK; Rook AH; Elenitsas R; Gasparro FP; Vowels BR
J Invest Dermatol; 1996 Aug; 107(2):235-42. PubMed ID: 8757769
[TBL] [Abstract][Full Text] [Related]
23. [Immunological monitoring of the efficacy of extracorporeal photopheresis for prevention of kidney transplant rejection].
Faenko AP; Chuksina YY; Zulkarnayev AB; Fedulkina VA; Vatazin AV; Kantaria RO
Urologiia; 2020 Sep; (4):73-78. PubMed ID: 32897018
[TBL] [Abstract][Full Text] [Related]
24. Technical comparison of four different extracorporeal photopheresis systems.
Brosig A; Hähnel V; Orsó E; Wolff D; Holler E; Ahrens N
Transfusion; 2016 Oct; 56(10):2510-2519. PubMed ID: 27456672
[TBL] [Abstract][Full Text] [Related]
25. Extracorporeal photopheresis promotes IL-1β production.
Yakut E; Jakobs C; Peric A; Michel G; Baal N; Bein G; Brüne B; Hornung V; Hackstein H
J Immunol; 2015 Mar; 194(6):2569-77. PubMed ID: 25681340
[TBL] [Abstract][Full Text] [Related]
26. Lymphocytes treated by extracorporeal photopheresis can down-regulate cytokine production in untreated monocytes.
Bladon J; Taylor PC
Photodermatol Photoimmunol Photomed; 2005 Dec; 21(6):293-302. PubMed ID: 16313240
[TBL] [Abstract][Full Text] [Related]
27. The role of extracorporeal photopheresis in the treatment of cutaneous T-cell lymphomas.
Atta M; Papanicolaou N; Tsirigotis P
Transfus Apher Sci; 2012 Apr; 46(2):195-202. PubMed ID: 22067605
[TBL] [Abstract][Full Text] [Related]
28. Comparison between 8-methoxypsoralen and 5-aminolevulinic acid in killing T cells of photopheresis patients ex vivo.
Holien T; Gederaas OA; Darvekar SR; Christensen E; Peng Q
Lasers Surg Med; 2018 Jul; 50(5):469-475. PubMed ID: 29460964
[TBL] [Abstract][Full Text] [Related]
29. Extracorporeal photopheresis: from solid organs to face transplantation.
Hivelin M; Siemionow M; Grimbert P; Lantieri L
Transpl Immunol; 2009 Jul; 21(3):117-28. PubMed ID: 19409991
[TBL] [Abstract][Full Text] [Related]
30. The immunological effects of extracorporeal photopheresis unraveled: induction of tolerogenic dendritic cells in vitro and regulatory T cells in vivo.
Lamioni A; Parisi F; Isacchi G; Giorda E; Di Cesare S; Landolfo A; Cenci F; Bottazzo GF; Carsetti R
Transplantation; 2005 Apr; 79(7):846-50. PubMed ID: 15818329
[TBL] [Abstract][Full Text] [Related]
31. CD209
Ni X; Austin M; Langridge T; Bojaxhi P; Bijani P; Wang X; Duvic M
Photodermatol Photoimmunol Photomed; 2020 Jul; 36(4):290-298. PubMed ID: 32187738
[TBL] [Abstract][Full Text] [Related]
32. Quality control of extracorporeal photochemotherapy: Proliferation assay using CFSE validated according to ISO 15189:2007 standards.
Faivre L; Lecouflet L; Liu WQ; Khadher I; Lahaie C; Vidal M; Legouvello S; Beaumont JL; Bierling P; Rouard H; Birebent B
Cytometry B Clin Cytom; 2015 Jan; 88(1):30-9. PubMed ID: 25227323
[TBL] [Abstract][Full Text] [Related]
33. Extracorporeal photophoresis increases sensitivity of monocytes from patients with graft-versus-host disease to HLA-DR-mediated cell death.
Setterblad N; Garban F; Weigl R; Assier E; Drillat P; Charron D; Dickinson A; Greinix H; Mooney N
Transfusion; 2008 Jan; 48(1):169-77. PubMed ID: 17900279
[TBL] [Abstract][Full Text] [Related]
34. Immunological monitoring of extracorporeal photopheresis after heart transplantation.
Dieterlen MT; Bittner HB; Pierzchalski A; Dhein S; Mohr FW; Barten MJ
Clin Exp Immunol; 2014 Apr; 176(1):120-8. PubMed ID: 24329680
[TBL] [Abstract][Full Text] [Related]
35. Extracorporeal photopheresis as second-line therapy for patients with acute graft-versus-host disease: does the number of cells treated matter?
Worel N; Lehner E; Führer H; Kalhs P; Rabitsch W; Mitterbauer M; Hopfinger G; Greinix HT
Transfusion; 2018 Apr; 58(4):1045-1053. PubMed ID: 29446444
[TBL] [Abstract][Full Text] [Related]
36. Maturation state of dendritic cells during the extracorporeal photopheresis and its relevance for the treatment of chronic graft-versus-host disease.
Spisek R; Gasova Z; Bartunkova J
Transfusion; 2006 Jan; 46(1):55-65. PubMed ID: 16398731
[TBL] [Abstract][Full Text] [Related]
37. Extracorporeal photopheresis practice patterns: An international survey by the ASFA ECP subcommittee.
Dunbar NM; Raval JS; Johnson A; Abikoff CM; Adamski J; Cooling LL; Grossman B; Kim HC; Marques MB; Morgan S; Schmidt AE; Sloan SR; Su LL; Szczepiorkowski ZM; West FB; Wong E; Schneiderman J
J Clin Apher; 2017 Aug; 32(4):215-223. PubMed ID: 27442906
[TBL] [Abstract][Full Text] [Related]
38. In vitro experiments demonstrate that monocytes and dendritic cells are rendered apoptotic by extracorporeal photochemotherapy, but exhibit unaffected surviving and maturing capacity after 30 Gy gamma irradiation.
Rao V; Saunes M; Jørstad S; Moen T
Scand J Immunol; 2008 Dec; 68(6):645-51. PubMed ID: 19055700
[TBL] [Abstract][Full Text] [Related]
39. Extracorporeal photopheresis attenuates murine graft-versus-host disease via bone marrow-derived interleukin-10 and preserves responses to dendritic cell vaccination.
Capitini CM; Davis JP; Larabee SM; Herby S; Nasholm NM; Fry TJ
Biol Blood Marrow Transplant; 2011 Jun; 17(6):790-9. PubMed ID: 21216299
[TBL] [Abstract][Full Text] [Related]
40. Increased production of interleukin-10 and interleukin-1 receptor antagonist after extracorporeal photochemotherapy in chronic graft-versus-host disease.
Craciun LI; Stordeur P; Schandené L; Duvillier H; Bron D; Lambermont M; Goldman M; Dupont E
Transplantation; 2002 Oct; 74(7):995-1000. PubMed ID: 12394844
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
